Affiliated with a Castle Connolly Top Hospital
Who is Dr. Nadeau, Allergist & Immunologist in Boston, MA?
What are Areas of Expertise for Dr. Nadeau?
Dr. Kari Nadeau, MD, PHD is a highly-rated, board-certified Allergist & Immunologist known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Nadeau empowers patients to confidently navigate their health journey, specializing in Allergy, Asthma, Clinical Trials, and comprehensive wellness support. Serving the Boston, MA community, Dr. Nadeau is dedicated to enhancing lives through expert, patient-centered care.
Where did Dr. Nadeau go to medical school and complete their residency?
Residency: Children's Hospital Program
Medical School: Harvard Medical School, Boston, Massachusetts | Harvard Medical School, Boston, Massachusetts
Is Dr. Nadeau board certified as an Allergist & Immunologist?
Yes, Dr. Kari Nadeau, MD, PHD is board certified by the American Board of Allergy and Immunology , American Board of Pediatrics
What languages does Dr. Nadeau speak?
Dr. Nadeau and their clinical team can communicate with patients in the following languages:
- English
- Spanish
What conditions does an Allergist & Immunologist like Dr. Nadeau typically treat?
As an Allergist & Immunologist, Dr. Nadeau diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Nadeau. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Hay Fever
- Pollen allergy
- Seasonal allergies
- Allergic rhinitis
ICD-10 Codes:
- J301: Allergic rhinitis due to pollen
Also known as:
- Allergy
- Allergic Reaction
- Hypersensitivity
- Allergic Condition
ICD-10 Codes:
- T7840XA: Allergy, unspecified, initial encounter
Also known as:
- Other Food Allergy
- Food Allergy
- Unspecified Food Allergy
- Multiple Food Allergies
- Food Hypersensitivity
ICD-10 Codes:
- Z91018: Allergy to other foods
Also known as:
- Unspecified drug allergy
- Drug Reactions
- Allergy to unknown medication
- Drug hypersensitivity
- Adverse reaction to medication
ICD-10 Codes:
- Z889: Allergy status to unspecified drugs, medicaments and biological substances
What procedures does an Allergist & Immunologist like Dr. Nadeau typically perform?
As an Allergist & Immunologist, procedures performed by Dr. Kari Nadeau may include:
- Allergy Consultation
- Allergy Follow Up
- Allergy Shots
- Allergy Testing
- Insect Bite(s)
- Sinus Surgeon Consultation
- Sinus Surgeon Follow Up
- Sinus Surgery
Please contact Dr. Nadeau's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Nadeau accept my insurance?
Dr. Nadeau accepts most major insurance plans. Important: Please call our office at (617) 632-0766 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Nadeau accept in Boston, MA?
Dr. Nadeau in Boston, MA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
CVS Health (formerly Aetna)
Medicare
Other TPA
Point32Health
View All Insurances
Where is Dr. Nadeau's office located?
What hospitals are Dr. Nadeau affiliated with?
Castle Connolly Top Hospital
This doctor is affiliated with a Castle Connolly Top Hospital.
Dr. Nadeau has admitting privileges at the following hospitals:
Recognitions
Publications
Whole-exome sequencing identifies tetratricopeptide repeat domain 7A, 2013
Differentiating the roles of STAT5B and STAT5A in human CD4(+) T cells, 2013
Markers of Antigen Presentation and Activation on Eosinophils and T Cells, 2013
Immunomodulatory effect of vancomycin on Treg in pediatric inflammatory bowel disease, 2013
Asthma Discordance in Twins Is Linked to Epigenetic Modifications of T Cells, 2012
Epigenetic modifications, 2012
Modulation of mTOR Effector Phosphoproteins in Blood Basophils from Allergic Patients, 2012
Persol Omics Profiling Reveals Dymic Molecular and Medical Phenotypes, 2012
Multiplex meta-alysis of R expression to identify genes with variants associated with immune, 2012
Oral Immunotherapy and Anti-IgE Antibody-Adjunctive Treatment for Food Allergy, 2012
The STAT5b Pathway Defect and Autoimmunity., 2012
The Safety of Peanut Oral Immunotherapy in Peanut-Allergic Subjects in a Single-Center Trial, 2012
Genotype, phenotype, and outcomes of nine patients with T-B plus NK plus SCID, 2011
T(H)1, T(H)2, and T(H)17 cells instruct monocytes to differentiate into specialized dendritic cell, 2011
Immunophenotyping of Peripheral Eosinophils Demonstrates Activation in Eosinophilic Esophagitis, 2011
Rapid oral desensitization in combition with omalizumab therapy in patients with cow's milk allergy, 2011
STAT5b Deficiency: An Unsuspected Cause of Growth Failure, Immunodeficiency, 2011
Basophil CD203c Levels Are Increased at Baseline, 2011
Migration of regulatory T cells toward airway epithelial cells is impaired, 2010
Individual Variation in the Germline Ig Gene Repertoire Inferred from Variable Region Gene, 2010
Bradykinin Inhibitors in Hereditary Angioedema, 2010
Ambient Air Pollution Impairs Regulatory T-Cell Function in Asthma., 2010
Increased Number of Regulatory T Cells in Children with Eosinophilic Esophagitis., 2010
Epoprostenol-Associated Pneumonitis: Diagnostic Use of a T Cell Proliferation Assay, 2010
Increased HLA-DR Expression on Tissue Eosinophils in Eosinophilic Esophagitis., 2010
TSLP directly impairs pulmory Treg function, 2010
Eotaxin and FGF enhance sigling through an extracellular sigl-related kise, 2010
Measurement and Clinical Monitoring of Human Lymphocyte Clolity by Massively Parallel V-D, 2009
Impaired IL-10-dependent Induction of Tolerogenic Dendritic Cells by CD4(+)CD25(hi)CD127(lo, 2009
Neotal Alloimmune Thrombocytopenia, 2009
Regulatory T cell dysfunction in subjects with common variable immunodeficiency complicated by, 2009
Selective deregulation in chemokine sigling pathways of CD4(+)CD25(hi)CD127(lo, 2009
T Lymphocytes and Its Subsets in Transplanted Small Bowel Treated with Alemtuzumab (Campath-1H), 2009
Idiopathic neutropenia of childhood is associated with Fas/FasL expression, 2008
XCL1 enhances regulatory activities of CD4(+)CD25(high)CD127(low, 2008
Increased cytotoxicity of CD4(+) invariant NKT cells against CD4(+)CD25(hi)CD127(lo, 2008
A novel mutation associated with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, 2008
Altered phosphorylated sigl transducer, 2007
Cutting edge: Decreased accumulation and regulatory function of CD4(+)CD25(high) T cells in human, 2006
Lgl1 is suppressed in oxygen toxicity animal models of bronchopulmory dysplasia, 2006
Successful conversion from conventiol immunosuppression to anti, 2001
Inhibition of CD40 ligand (CD154) in the treatment of factor VIII inhibitors., 2000
Rel allograft protection with losartan in Fisher -> Lewis rats: Hemodymics, macrophages, 2000
Cloning and characterization of the two enzymes responsible for trypanothione biosynthesis in, 1998
Effects of explosive brain death on cytokine activation of peripheral organs in the rat, 1998
Late blockade of T cell costimulation interrupts progression of experimental chronic allograft, 1998
Influence of initial antigen-independent events on acute allograft rejection, 1998
Infection-associated macrophage activation accelerates chronic rel allograft rejection in rats, 1997
Prevention of late rel changes after initial ischemia, 1997
CD28-B7 blockade in organ dysfunction secondary to cold ischemia, 1997
The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury, 1997
Cellular and molecular predictors of chronic rel dysfunction after initial ischemia, 1997
The cytokine-adhesion molecule cascade in ischemia, 1997
Sequential cellular and molecular kinetics in acutely rejecting rel allografts in rats, 1997
Uccompanied children in detention in the US, 1997
Immigrating uccompanied miners - A neglected minority?, 1997
Nephron mass modulates the hemodymic, cellular, and molecular response of the rat rel allograft, 1997
Inhibition of CD28-B7 T-cell costimulatory activation pathway affects intragraft cytokine, 1997
Initial ischemia/reperfusion injury influences late functiol and structural changes in the kidney, 1997
Early cellular and molecular changes in ischemia, 1997
Sequential cytokine expression in rel allografts in rats immunosuppressed with maintence, 1996
Blockade of T-cell costimulation prevents development of experimental chronic rel allograft, 1996
Inflammatory mediators, cells and their products in acute host alloresponsiveness., 1996
Prevention of functiol, structural, 1995
SEQUENTIAL CYTOKINE DYMICS IN CHRONIC REJECTION OF RAT REL-ALLOGRAFTS, 1995
QUANTITATION OF THE INTERACTION OF THE IMMUNOSUPPRESSANT DEOXYSPERGUALIN AND ALOGS WITH HSC70 AND HS, 1994
MOLECULAR AND BIOCHEMICAL-COMPARISON OF THE 70-KDA HEAT-SHOCK PROTEINS OF TRYPANOSOMA-CRUZI, 1994
HSP90 CHAPERONINS POSSESS ATPASE ACTIVITY AND BIND HEAT, 1993
STUDIES ON THE INTERACTION OF THE IMMUNOSUPPRESSANT 15-DEOXYSPERGUALIN WITH HEAT-SHOCK PROTEINS, 1993
83-KILODALTON HEAT-SHOCK PROTEINS OF TRYPANOSOMES ARE POTENT PEPTIDE-STIMULATED ATPASES, 1992
KINETIC ISOTOPE EFFECT ALYSIS OF THE REACTION CATALYZED BY TRYPANOSOMA, 1992
PURIFICATION OF GLUTATHIONYLSPERMIDINE AND TRYPANOTHIONE SYNTHETASES FROM CRITHIDIA-FASCICULATA, 1992
MOLECULAR STUDIES ON TRYPANOTHIONE REDUCTASE - AN ANTIPARASITIC TARGET ENZYME, 1992
MOLECULAR STUDIES ON TRYPANOTHIONE REDUCTASE, A TARGET FOR ANTIPARASITIC DRUGS, 1991
A TEST FOR GENETIC EXCHANGE IN MIXED INFECTIONS OF LEISHMANIA-MAJOR IN THE SAND FLY PHLEBOTOMUS, 1991
THE PROMOTER OF THE LATENCY-ASSOCIATED TRANSCRIPTS OF HERPES, 1991
What is Dr. Nadeau's NPI number?A National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Nadeau's National Provider Identifier (NPI) number is 1871652644.
What common questions do patients ask about Dr. Nadeau?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Nadeau
